Table 7 Changes in Lipid, apolipoprotein and lipoprotein values of subjects after 12–14 weeks on placebo or α-CD either measured by conventional biochemistry methods or by NMR (mean ± SEM)
From: Randomized double blind clinical trial on the effect of oral α-cyclodextrin on serum lipids
Lipids and Lipoproteins | Placebo | α-CD | p |
|---|---|---|---|
Cholesterol (<200 mg/dL) | 180 ± 4 | 180 ± 4 | 0.82 |
Triglycerides (<150 mg/dL) | 97 ± 6 | 100 ± 6 | 0.92 |
LDL-C (<100 mg/dL) | 103 ± 3 | 103 ± 3 | 0.91 |
LDL-p (<1000 nmol/L) | 1038 ± 47 | 1005 ± 45 | 0.16 |
sLDL-p (<1317 nmol/L) | 405 ± 38 | 365 ± 35 | 0.04a |
HDL-C (<40 mg/dL) | 58 ± 2 | 60 ± 2 | 0.95 |
HDL-p (24–49 umol/L) | 35 ± 1 | 35 ± 1 | 0.90 |